Hepatitis-B-Immunglobulin Behring, Injektionslösung

7680006740037 CH-674 Injektionslösung
Hepatitis-B-Immunglobulin Behring, Injektionslösung
Hepatitis-B-Immunglobulin Behring, Injektionslösung
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
1
Selling units
1
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
05/02/2026
Summary of Product Characteristics
Français
05/02/2026
Summary of Product Characteristics
Italien
05/02/2026

Detailed composition

Substance Quantity Type Category
immunoglobulinum humanum hepatitidis B
- Substance Wirkstoff (Principe actif)
immunoglobulinum humanum normale
- Substance WIZUS
proteina
- Substance WIZUS
immunoglobulinum humanum A
- Substance RESI
glycinum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrium
- Substance HBESI
acidum hydrochloridum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Authorization holder

CSL Behring AG

3014 Bern

Authorization information

Swissmedic authorization number
674
Drug name
Hepatitis-B-Immunglobulin Behring, Injektionslösung
Galenic form
LSINJ
ATC Code
J06BB04
Authorization status
Z
Dispensing category
B
First authorization
01/03/2004
Authorization expiration date
31/12/9999
IT Number
08.09.
Domain
Human medicine
Field of application
passive Immunisierung gegen Hepatitis B, ab Geburt

Package details

Description (FR)
HEPATITIS B-IG Behring sol inj 200 U.I. 1 ml PFS
Description (DE)
HEPATITIS B-IG Behring Inj Lös 200 I.U. 1 ml PFS
Market launch
01/03/2004
Narcotic (BTM)
No

Application methods

IMU

Other package sizes (1)

HEPATITIS B-IG Behring sol inj 1000 U.I. 5 ml PFS
5 ML
GTIN: 7680006740044
View
Buy us a coffee Explore the data